In families carrying the p16-Leiden mutation, the relative risk of developing cancers other than melanoma is 4.4 [29] with a cumulative risk of developing pancreatic cancer before the age of 75 of 17 % [30]. The gene discussed is CDKN2A; the disease is familial pancreatic carcinoma.